ŠTORK, M. Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2018, 2018, vol. 65, no. 4, s. 585-591.